Related Experiment Video
Updated: May 23, 2026
Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
Effects of Functional Fascial Taping on pain and function in patients with non-specific low back pain: a pilot
Shu-Mei Chen1, Ron Alexander, Sing Kai Lo
1Department of Physical Therapy, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
Objectives:
To compare the short-term and medium-term effect of Functional Fascial Taping to placebo taping on pain and function in people with non-specific low back pain.
Design:
A pilot randomized controlled trial with a 2-week intervention, and 2-, 6- and 12-week follow-up.
Setting:
Individuals with non-specific low back pain recruited from local communities.
Participants:
Forty-three participants with non-specific low back pain for more than 6 weeks were randomized into either Functional Fascial Taping group (n = 21) or placebo group (n = 22).
Interventions:
The intervention group was treated with Functional Fascial Taping while the control group was treated with placebo taping. Both groups received four treatments over 2 weeks.
Main Outcome Measures:
Worst and average pain and function were assessed at baseline, after the 2-week intervention, and at 6 and 12 weeks follow-up.
Results:
The Functional Fascial Taping group demonstrated significantly greater reduction in worst pain compared to placebo group after the 2-week intervention (P = 0.02, effect size = 0.74; 95% confidence interval 0.11-1.34). A higher proportion of participants in Functional Fascial Taping group attained the minimal clinically important difference in worst pain (P = 0.007) and function (P = 0.007) than those in placebo group after the 2-week intervention. There were no significant differences in either group's disability rating or clinically important difference in average pain at any time.
Conclusions:
Functional Fascial Taping reduced worst pain in patients with non-acute non-specific low back pain during the treatment phase. No medium-term differences in pain or function were observed.
